Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, May 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 73 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,902 followers.

New Research: Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy: Osteoporosis is age-related deterioration in bone mass and micro-architecture. Denosumab is a novel human monoclonal antibody for… https://t.co/h

14 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.